相似文献
1
COVID-19 and diabetes: What do we know so far?新型冠状病毒肺炎与糖尿病：目前我们了解多少？
Exp Biol Med (Maywood). 2022 Aug;247(15):1330-1334. doi: 10.1177/15353702221108914. Epub 2022 Jul 27.
2
Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality.高血糖诱导组织蛋白酶 L 成熟与糖尿病合并症和 COVID-19 死亡率相关。
Elife. 2024 Aug 16;13:RP92826. doi: 10.7554/eLife.92826.
3
Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.基于草药的疗法治疗感染 SARS-CoV-2 的糖尿病患者。
Mol Biol Rep. 2024 Feb 20;51(1):316. doi: 10.1007/s11033-024-09291-1.
4
COVID-19 and diabetes: A bidirectional relationship.2019冠状病毒病与糖尿病：一种双向关系。
Clin Investig Arterioscler. 2021 May-Jun;33(3):151-157. doi: 10.1016/j.arteri.2020.10.001. Epub 2020 Oct 28.
5
Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?高血糖、糖尿病并发症与 SARS-CoV-2 作用的人类蛋白的基因网络：共病的分子基础是什么？
Int J Mol Sci. 2022 Jun 29;23(13):7247. doi: 10.3390/ijms23137247.
6
Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2.合并糖尿病对感染野生型或德尔塔变异株 SARS-CoV-2 的 COVID-19 患者临床特征的影响。
Front Endocrinol (Lausanne). 2022 May 4;13:861443. doi: 10.3389/fendo.2022.861443. eCollection 2022.
7
COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.COVID-19 与糖尿病——两大巨头的碰撞：从病理生理学到管理。
Front Endocrinol (Lausanne). 2022 Aug 19;13:974540. doi: 10.3389/fendo.2022.974540. eCollection 2022.
8
The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.糖代谢紊乱和糖尿病对新型严重急性呼吸综合征冠状病毒2发病机制及预后的影响：文献系统综述
Curr Diabetes Rev. 2022;18(3):e060821195355. doi: 10.2174/1573399817666210806104349.
9
An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.COVID-19 与糖尿病患者：住院环境中的病理生理学与注意事项概述。
Diabet Med. 2021 Mar;38(3):e14509. doi: 10.1111/dme.14509. Epub 2021 Feb 5.
10
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?糖尿病是否是 2019 年冠状病毒病（COVID-19）的危险因素？
Acta Diabetol. 2020 Nov;57(11):1275-1285. doi: 10.1007/s00592-020-01586-6. Epub 2020 Aug 31.
引用本文的文献
1
Predictive value of hematocrit, serum albumin level difference, and fibrinogen-to-albumin ratio for COVID-19-associated acute respiratory failure.血细胞比容、血清白蛋白水平差异及纤维蛋白原与白蛋白比值对新型冠状病毒肺炎相关急性呼吸衰竭的预测价值
Heliyon. 2024 Jun 20;10(12):e33326. doi: 10.1016/j.heliyon.2024.e33326. eCollection 2024 Jun 30.
2
Epidemiological Evaluation of Events Allegedly Attributable to COVID-19 Vaccination: A Cross-Sectional Study in the Brazilian Amazon.对疑似归因于新冠疫苗接种事件的流行病学评估：巴西亚马逊地区的一项横断面研究
Pharmaceuticals (Basel). 2024 Feb 27;17(3):304. doi: 10.3390/ph17030304.
3
New Insights into the Effects of SARS-CoV-2 on Metabolic Organs: A Narrative Review of COVID-19 Induced Diabetes.严重急性呼吸综合征冠状病毒2对代谢器官影响的新见解：关于2019冠状病毒病诱发糖尿病的叙述性综述
Diabetes Metab Syndr Obes. 2024 Mar 21;17:1383-1389. doi: 10.2147/DMSO.S454408. eCollection 2024.
4
Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused.糖尿病，全球增长最快的公共卫生问题：应关注早期检测。
Health Sci Rep. 2024 Mar 22;7(3):e2004. doi: 10.1002/hsr2.2004. eCollection 2024 Mar.
5
SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein.SAR、分子对接和分子动力学模拟天然抑制剂对 SARS-CoV-2 Mpro 刺突蛋白的作用。
Molecules. 2024 Mar 4;29(5):1144. doi: 10.3390/molecules29051144.
6
Role of inflammation in determining the severity of COVID-19 infection in patients with diabetes: A comparative study.炎症在确定糖尿病患者 COVID-19 感染严重程度中的作用：一项对比研究。
Medicine (Baltimore). 2023 Dec 15;102(50):e36641. doi: 10.1097/MD.0000000000036641.
本文引用的文献
1
Increase in blood glucose level and incidence of diabetic ketoacidosis in children with type 1 diabetes mellitus in the Daegu-Gyeongbuk area during the coronavirus disease 2019 (COVID-19) pandemic: a retrospective cross-sectional study.2019冠状病毒病（COVID-19）大流行期间大邱-庆北地区1型糖尿病儿童血糖水平升高及糖尿病酮症酸中毒发病率：一项回顾性横断面研究
J Yeungnam Med Sci. 2022 Jan;39(1):46-52. doi: 10.12701/yujm.2021.01221. Epub 2021 Aug 26.
2
Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis.晚期糖基化终产物（AGEs）及其受体 RAGE 可调节与年龄相关的 COVID-19 发病率和死亡率。综述与假说。
Int Immunopharmacol. 2021 Sep;98:107806. doi: 10.1016/j.intimp.2021.107806. Epub 2021 May 24.
3
SARS-CoV-2 variants: A double-edged sword?SARS-CoV-2 变体：一把双刃剑？
Exp Biol Med (Maywood). 2021 Aug;246(15):1721-1726. doi: 10.1177/15353702211014146. Epub 2021 May 22.
4
Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients.晚期糖基化终末产物轴：糖尿病患者感染新型冠状病毒肺炎后发展为重症的一个危险因素。
World J Diabetes. 2021 May 15;12(5):590-602. doi: 10.4239/wjd.v12.i5.590.
5
Diabesity Associates with Poor COVID-19 Outcomes among Hospitalized Patients.糖尿病肥胖症与住院患者中COVID-19的不良预后相关。
J Obes Metab Syndr. 2021 Jun 30;30(2):149-154. doi: 10.7570/jomes20121.
6
Hypertension as a sequela in patients of SARS-CoV-2 infection.新型冠状病毒感染患者的后遗症高血压。
PLoS One. 2021 Apr 28;16(4):e0250815. doi: 10.1371/journal.pone.0250815. eCollection 2021.
7
A mini-review on the effects of COVID-19 on younger individuals.关于 COVID-19 对年轻人影响的小型综述。
Exp Biol Med (Maywood). 2021 Feb;246(3):293-297. doi: 10.1177/1535370220975118. Epub 2020 Nov 19.
8
COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions.COVID-19 作为抗原过剩条件下的免疫复合物过敏：理论发病机制过程及潜在治疗干预建议。
Front Immunol. 2020 Oct 21;11:566000. doi: 10.3389/fimmu.2020.566000. eCollection 2020.
9
COVID-19 and diabetes mellitus: from pathophysiology to clinical management.新型冠状病毒肺炎与糖尿病：从病理生理学到临床管理。
Nat Rev Endocrinol. 2021 Jan;17(1):11-30. doi: 10.1038/s41574-020-00435-4. Epub 2020 Nov 13.
10
Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications.肥胖、胰岛素抵抗与2型糖尿病：关联及治疗意义
Diabetes Metab Syndr Obes. 2020 Oct 9;13:3611-3616. doi: 10.2147/DMSO.S275898. eCollection 2020.
Zotero 插件